RAC 6.80% $1.89 race oncology ltd

Ann: H1 2023 Preclinical and Clinical Programs Update, page-85

  1. 1,118 Posts.
    lightbulb Created with Sketch. 301
    can we add to the speculation the involvement of a third party with deep pockets… US trials expensive.

    (My first guess would have been cardio-protect, but potential CoH involvement makes FTO more likely).
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.